To determine the binding patterns of the three proteins, we performed co-IP assays with anti-PHB2 or anti-NDUFV1 antibodies in the NDUFS1-knockdown CRC cells (Fig. 6G, H). This evidence concerns the gene PHB2 and colorectal carcinoma.